| Revenue Growth | Q3 revenue $20.2M, up 38% from $14.6M in Q3 2025. |
|---|---|
| Mgmt Confidence | Confident in record revenue but cautious, lowering EBITDA margin guidance for 2026. |
| Demand Visibility | Expect at least $65M in shipped and on-hand orders by year-end. |
| Order Book | On-hand orders contribute to $65M year-end revenue target. |
| Margin Trends | Gross margin 39.3%; OEE increased from 40% to 55% year-over-year. |
| Op. Leverage | Indirect costs down seven-figure amount; expenses growing slower than top-line revenue. |
| Vol vs Price | Growth driven by strategic brand partner expansion and favorable product mix. |
| Segment Growth | Strong growth in SPF-infused facial care, complexion products, and makeup. |
| New Clients | Over 60 brand partners and 300 SKUs currently in market. |
| Capex & Debt | Manufacturing footprint expanded from 80,000 to 300,000 square feet since 2022. |
| Regulatory | FDA approval of BMT UV filter creates new formulation opportunities for 2027. |
| Commentary | Transform and Transcend strategy focused on lean management and operational efficiency. |
| New Launches | Hybrid BMT products expected to reach consumers in 2027. |
Growth
Q3 revenue grew 38% to $20.2M; gross margin expanded 1,550 bps to 39.3%.
Outlook
Guiding to $65M year-end revenue and 30% gross profit floor for 2026.
Risks
Management pivoted on EBITDA guidance, lowering it from double-digits to 'slightly below' without specific figures.
The company's earnings call, NASDAQ: SLSN, and its 8-K filed with the SEC. Summary written with AI assistance from the call.
Earnings call webcast ↗ Watch on YouTube ↗
Solesence, Inc.: key numbers
- Share price
- $1.60Close, Nov 16
- Market cap
- $113M
- Shares outstanding
- 70.65MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Perfumes, Cosmetics & Other Toilet PreparationsSIC 2844
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Solesence, Inc.
All →Solesence Q3 2026 Results: Turns Profitable, Net Income $3.67M
Solésence, Inc. reported a net income of $3.67 million for the third quarter of 2026, a significant recovery from a $1.02 million net loss in the prior year period, driven by a 38% increase in total revenue. For the nine months ended September 30, 2026, the company generated $8.4 million in cash from operating activities, compared to a $10.4 million cash burn in the same period of 2025.
- Key figure
- Net income $3.67M
Solesence Financial Results
Solésence reported record third quarter 2026 financial results, with revenue increasing 38% year-over-year to $20.2 million. The company achieved its highest-ever quarterly net income of $3.7 million, driven by operational excellence and strong demand from brand partners.
- Term
- Q3 2026
“We’re very pleased that Solésence delivered solid top line growth as well as steady operational and strategic progress in the third quarter, driven by key milestones across our Transform and Transcend framework. Most notably, we reached a major turning point by completing the primary investment and implementation phase of our first pillar, operational excellence. This elevated capacity and efficiency position us to meet robust demand from our brand partners today while seamlessly scaling for tomorrow. Paired with our continued innovation in novel formulations and expanding global presence, Solésence is uniquely positioned to deliver long-term, profitable growth and lead the market in meeting evolving consumer needs.”
Kevin Cureton, President and CEO
“By pairing record revenue and net income with strong margin expansion, we have positioned Solésence for sustained growth. The operational and financial improvements achieved throughout 2026 provide a strong foundation as we look ahead to 2027.”
Laura Riffner, Chief Financial Officer
Solesence Debt Financing Update with Beachcorp, LLC
Solésence, Inc. entered into amendments for three separate loan agreements with affiliates of its controlling shareholder, Bradford T. Whitmore. The amendments extend the maturity dates for the Term Loan, A/R Loan, and Revolving Loan from April 30, 2027, to May 31, 2028.
- Counterparty
- Beachcorp, LLC
- Term
- through May 31, 2028
Solesence Nasdaq/NYSE Compliance Notice
Solésence, Inc. received a deficiency notice from Nasdaq on September 29, 2026, because its common stock closing bid price fell below the $1.00 minimum requirement for 30 consecutive trading days. The company has 180 calendar days, until March 29, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive trading days. If compliance is not met by then, the company may be eligible for an additional 180-day grace period if it meets other listing standards.
- Counterparty
- Nasdaq
- Term
- 180 days